Piramal Pharma Ltd
Piramal Pharma Waste Data Preview
In 2023, Piramal Pharma conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
|---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data.  | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data.  | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
Insights into Piramal Pharma's Waste Treatment Practices
In 2023, Piramal Pharma generated a total of 15,433 metric tonnes of waste.
Of this amount, 35.15% of Piramal Pharma's total waste generated was recovered through methods such as recycling, reuse, or composting, while 64.85% was disposed of through landfilling, incineration, or combustion.
Piramal Pharma's Waste Recovery Rate
How much of Piramal Pharma's waste is recycled or recovered?
In 2023, Piramal Pharma reported a total waste generation of 15,433 metric tonnes, of which 35.15% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Piramal Pharma is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Has Piramal Pharma reduced its environmental waste footprint over time?
Since 2021, Piramal Pharma's total waste generation increased by 4.9%, including a 5.97% increase in 2023, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.
Over the same period, Piramal Pharma's waste recovery rate declined by 28.14%, with a further 37.1% drop in 2023, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.
Overall, Piramal Pharma is generating more waste while simultaneously backsliding on recovery efforts, both in the short and long term. This dual negative trend raises concerns about the company’s waste management priorities and its alignment with sustainability goals.
Piramal Pharma’s Waste Recovery vs. Disposal Over Time
- Total Waste Disposed
- Total Waste Recovered
Insights into Piramal Pharma’s Generation of Hazardous and Non-Hazardous Waste
In 2023, Piramal Pharma generated a total of 15,433 metric tonnes of waste.
Of this amount, 81.93% of Piramal Pharma's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 18.06% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Piramal Pharma’s Hazardous vs Non-Hazardous Waste Over Time
- Total Non-Hazardous Waste Generated
- Total Hazardous Waste Generated
How Piramal Pharma reduced the environmental impact of its waste?
Since 2021, Piramal Pharma's total waste generation increased by 4.9%, including a 5.97% rise in 2023, reflecting a persistent upward trend that could be linked to operational growth, inefficient material use, or limited investment in waste prevention systems.
Over the same period, the share of hazardous waste in Piramal Pharma's total output increased by 12.58%, including a further 7.25% rise in 2023, suggesting a troubling upward shift toward more environmentally harmful waste streams that could raise compliance costs and environmental risks.
Overall, Piramal Pharma has seen a continuous rise in both total waste and hazardous waste over time, signaling a worsening environmental impact that may require urgent reassessment of material sourcing, production processes, or waste mitigation strategies.